<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://revistakdea360.com.br/noticia/74923/pfizer-redefine-o-futuro-da-oncologia-com-avancos-cientificos-apresentados-na-asco</loc><lastmod>2026-07-01T00:08:34-03:00</lastmod><priority>0.8</priority><changefreq>daily</changefreq><image:image><image:loc>https://revistakdea360.com.br/images/noticias/74923/29062310_national-c.jpg</image:loc><image:caption>Pfizer redefine o futuro da oncologia com avanços científicos apresentados na ASCO</image:caption></image:image></url><url><loc>https://revistakdea360.com.br/noticia/74922/elaine-ribeiro-cardoso-celebra-encerramento-da-primeira-edicao-do-acelera-osc-na-unifesp-e-destaca-papel-transformador-das-oscs-no-brasil</loc><lastmod>2026-07-01T00:04:53-03:00</lastmod><priority>0.8</priority><changefreq>daily</changefreq><image:image><image:loc>https://revistakdea360.com.br/images/noticias/74922/28063149_WhatsApp_I.jpeg</image:loc><image:caption>Elaine Ribeiro Cardoso celebra encerramento da primeira edição do Acelera OSC na UNIFESP e destaca papel</image:caption></image:image></url></urlset>
